Cobblestone Capital Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,700
| Closed | -$202K | – | 281 |
|
|
2023
Q3 | $202K | Sell |
2,700
-1,072
| -28% | -$82.5K | 0.02% | 253 |
|
|
2023
Q2 | $291K | Hold |
3,772
| – | – | 0.02% | 218 |
|
|
2023
Q1 | $313K | Sell |
3,772
-99
| -3% | -$8.2K | 0.02% | 210 |
|
|
2022
Q4 | $332K | Hold |
3,871
| – | – | 0.03% | 210 |
|
|
2022
Q3 | $239K | Sell |
3,871
-65
| -2% | -$4.1K | 0.02% | 220 |
|
|
2022
Q2 | $243K | Hold |
3,936
| – | – | 0.02% | 223 |
|
|
2022
Q1 | $234K | Sell |
3,936
-300
| -7% | -$19.2K | 0.02% | 233 |
|
|
2021
Q4 | $308K | Buy |
4,236
+300
| +8% | +$20.7K | 0.02% | 218 |
|
|
2021
Q3 | $275K | Hold |
3,936
| – | – | 0.02% | 222 |
|
|
2021
Q2 | $271K | Sell |
3,936
-155
| -4% | -$10.3K | 0.02% | 226 |
|
|
2021
Q1 | $264K | Buy |
+4,091
| New | +$264K | 0.02% | 226 |
|
|
2019
Q1 | – | Sell |
-31,786
| Closed | -$1.99M | – | 245 |
|
|
2018
Q4 | $1.99M | Sell |
31,786
-35,324
| -53% | -$2.47M | 0.2% | 65 |
|
|
2018
Q3 | $5.18M | Sell |
67,110
-89
| -0.1% | -$6.72K | 0.49% | 49 |
|
|
2018
Q2 | $4.76M | Buy |
67,199
+800
| +1% | +$56.5K | 0.47% | 55 |
|
|
2018
Q1 | $5.01M | Buy |
66,399
+4,134
| +7% | +$329K | 0.51% | 50 |
|
|
2017
Q4 | $4.46M | Sell |
62,265
-6,570
| -10% | -$499K | 0.44% | 55 |
|
|
2017
Q3 | $5.58M | Buy |
68,835
+2,581
| +4% | +$197K | 0.69% | 44 |
|
|
2017
Q2 | $4.69M | Sell |
66,254
-2,994
| -4% | -$199K | 0.61% | 48 |
|
|
2017
Q1 | $4.7M | Buy |
69,248
+2,043
| +3% | +$144K | 0.63% | 46 |
|
|
2016
Q4 | $4.81M | Sell |
67,205
-3,259
| -5% | -$242K | 0.66% | 44 |
|
|
2016
Q3 | $5.58M | Buy |
70,464
+891
| +1% | +$72.4K | 0.79% | 37 |
|
|
2016
Q2 | $5.8M | Buy |
69,573
+31,895
| +85% | +$2.83M | 0.83% | 33 |
|
|
2016
Q1 | $3.46M | Buy |
37,678
+3,066
| +9% | +$276K | 0.51% | 53 |
|
|
2015
Q4 | $3.5M | Sell |
34,612
-498
| -1% | -$51.8K | 0.53% | 52 |
|
|
2015
Q3 | $3.45M | Sell |
35,110
-414
| -1% | -$46K | 0.55% | 49 |
|
|
2015
Q2 | $4.16M | Buy |
35,524
+850
| +2% | +$92.9K | 0.63% | 44 |
|
|
2015
Q1 | $3.4M | Sell |
34,674
-375
| -1% | -$38.1K | 0.53% | 49 |
|
|
2014
Q4 | $3.3M | Sell |
35,049
-1,045
| -3% | -$108K | 0.59% | 52 |
|
|
2014
Q3 | $3.84M | Sell |
36,094
-20,766
| -37% | -$2.03M | 0.71% | 48 |
|
|
2014
Q2 | $4.71M | Buy |
56,860
+53,734
| +1,719% | +$4.18M | 0.88% | 39 |
|
|
2014
Q1 | $222K | Buy |
3,126
+40
| +1% | +$3.14K | 0.04% | 149 |
|
|
2013
Q4 | $232K | Buy |
+3,086
| New | +$215K | 0.04% | 145 |
|
Other funds holding GILD
Cobblestone Capital Advisors's GILD Position: Q4 2023 in Review
Cobblestone Capital Advisors sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 2,700 shares — an estimated $202K sold.
Cobblestone Capital Advisors first reported a position in GILD in Q4 2013 and held it in 32 quarters. The position peaked at $5.8M in Q2 2016. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.
- Cobblestone Capital Advisors reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
- Cobblestone Capital Advisors sold 2,700 Gilead Sciences shares in Q4 2023, an estimated $202K.
- Cobblestone Capital Advisors first reported a position in Gilead Sciences in Q4 2013 and held it in 32 quarters.
- Cobblestone Capital Advisors's Gilead Sciences position peaked at $5.8M in Q2 2016.
- 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.
Based on Cobblestone Capital Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.